New Hope for Liver Cancer Patients: Breakthrough Treatment Receives UK Recognition
A promising new treatment for a common type of liver cancer has been given a special recognition in the UK, […]
New Drug Trial Begins for Patients with Hard-to-Treat Autoimmune Diseases
A pharmaceutical company called Oblenio has started giving a new experimental drug, called LBL-051, to patients in the first phase
First patient treated in groundbreaking cancer vaccine study for oesophageal cancer
A new experimental cancer vaccine called ITOP1 has been given to the first patient in a clinical trial led by
Pharmaceutical News
New Natural Weight Loss Supplement Shows Promise in Fat Reduction Without Muscle Loss
A new natural supplement called Calocurb offers a different approach to weight loss compared to popular prescription medications like semaglutide.
OrbusNeich Begins Important Clinical Trial in Japan for a New Heart Treatment
OrbusNeich, a company that makes medical devices for heart treatments, has just started a major clinical trial in Japan with
Pharmaceutical News
Johnson & Johnson Teams Up with Sail Biomedicines to Develop New Treatments for Immune Diseases
Johnson & Johnson, through its subsidiary Janssen Biotech, has partnered with Sail Biomedicines, a U.S. biotechnology company, to develop innovative
New Treatment Recommendation for Severe Itching in Liver Disease: Lynavoy Could Soon Be Available in Europe
A European medical committee has recommended approving a new medication called Lynavoy to treat severe itching in adults with a
Pharmaceutical News
WHO Releases First-Ever Global Plan to Make Medicine Production Greener
The World Health Organization (WHO) has just created the first worldwide recommendations to help medicine regulators speed up the shift
New Treatment Approved for a Specific Type of Advanced Lung Cancer
GlaxoSmithKline (GSK) has received approval from the US Food and Drug Administration (FDA) for a new cancer treatment called Jideytro
Pharmaceutical News
BeOne Medicines Expands New Jersey Facility with $300 Million Investment to Boost Cancer Drug Production
BeOne Medicines, a pharmaceutical company based in Hopewell, New Jersey, is spending $300 million to expand its main manufacturing and